Cancer Organoid News, January 27, 2020
Updated: Feb 8
Open postdoc position in Géraldine Guasch's lab in Marseille, studying a model of ano-rectal cancer.
Image by Frederic Raux from Pixabay.
Open postdoc position in Tullia Bruno’s lab at the University of Pittsburgh working on B cells in cancer.
Image from University of Pittsburgh.
Universal cancer therapy? Newly discovered MR1-binding TCR targets 10 different types of cancer, including breast, lung, colon and prostate cancer, while sparing healthy tissue in vitro and in animal models.
Patient-specific immune-enhanced organoids improve immunotherapy screening.
Image showing a mouse lymph node sourced from Wikimedia Commons.
Abstract submissions still open for the British Society of Immunology Checkpoint Blockade meeting in Birmingham. The deadline is February 20, 2020.
Image from the British Society of Immunology.